GoodRx Plans Fourth Quarter Earnings Announcement
GoodRx Holdings, Inc. (Nasdaq: GDRX), recognized as the leading prescription savings platform in the U.S., has announced an important date for investors and health-conscious consumers alike. The company is set to release its financial results for the fourth quarter and full year of 2024 on a Thursday morning, ensuring that its stakeholders are updated on key financial metrics.
Details of the Conference Call
The earnings report will be made public before U.S. markets open on February 27, 2025. Following this release, GoodRx management will conduct a conference call and webcast at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time). This call will allow the management team to discuss the financial results and provide insights into the company's future direction.
How to Join the Conference Call
To participate in the conference call, interested parties are encouraged to pre-register for access. Upon registration, participants will receive crucial information, including dial-in particulars and a unique code necessary for joining the discussion. For those who prefer to follow along online, the event will also be available via a live webcast on the GoodRx investor relations website, which features essential materials relevant to the earnings report.
Webcast Archive Availability
For those who are unable to attend the live call, GoodRx will provide an archived version of the webcast one hour after the event concludes. This archived version will be accessible for at least 30 days on the company’s investor relations portal, allowing investors and the public to catch up on the insights laid out during the call.
Understanding GoodRx's Services
GoodRx stands out as a trusted resource for millions of consumers, connecting them with significant savings on prescription medications. Having established itself since 2011, GoodRx has already helped consumers save over $75 billion on their prescription costs. The platform serves around 30 million individuals and collaborates with over one million healthcare professionals yearly, providing access to both generic and brand-name medications across more than 70,000 pharmacies nationwide.
A Platform for Affordable Healthcare
As the reliance on digital platforms for healthcare information and cost-saving measures continues to grow, GoodRx remains dedicated to offering extensive resources for both consumers and healthcare practitioners. The company emphasizes not just savings on medications but also delivering comprehensive healthcare research and vital information necessary for informed decision-making by users.
Keeping Investors Informed
GoodRx maintains a proactive approach to communication with its investors, consistently posting valuable updates on its investor relations website. Company representatives encourage both current and potential investors to regularly check the website for materials that may contain important non-public information, press releases, and updates about the company’s performance and strategic initiatives.
Frequently Asked Questions
What is the date of GoodRx's fourth quarter earnings release?
GoodRx will release its fourth quarter and full year 2024 earnings on February 27, 2025.
How can I access the earnings conference call?
Participants need to pre-register to access the conference call. Registration details will be provided on the GoodRx investor relations website.
Will a recording of the conference call be available?
Yes, an archived version of the webcast will be available approximately one hour after the call and accessible for 30 days.
What services does GoodRx provide?
GoodRx offers a platform that allows consumers to find pricing for generic and brand-name medications and provides savings opportunities at numerous pharmacies across the nation.
How does GoodRx ensure it keeps investors informed?
GoodRx posts significant information on its investor relations website and encourages stakeholders to visit regularly for updates and critical announcements.
